tert-Butyl 4-benzoylpiperidine-1-carboxylate
CAS: 193217-39-9
Rif. 3D-THA21739
| 5g | 904,00 € | ||
| 50g | 5.466,00 € |
Informazioni sul prodotto
Tert-butyl 4-benzoylpiperidine-1-carboxylate (TBCPC) is a novel amide antagonist that has been shown to inhibit HIV entry into cells. TBCPC has been shown to have an oral bioavailability of 100% and a half-life of 10 hours in rats. This compound also had no effect on the pharmacokinetic profile of other drugs, which could make it a good candidate for replacing other anti-HIV drugs. TBCPC has the potential to be developed as a ccr5 antagonist and may have potential applications in treating diseases such as cancer, inflammatory bowel disease, and AIDS.
Proprietà chimiche
Richiesta tecnica su: 3D-THA21739 tert-Butyl 4-benzoylpiperidine-1-carboxylate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
